HARPOON THERAPEUTICS
Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the bodyโs immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patientโs own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells. Using its proprietary Tri-specific T cell Activating Construct๏ (TriTAC), platform, Harpoon is developing a pipeline of novel T cell engagers, or TriTACs, initially focused on the treatment of solid tumors and hematologic malignancies. Harpoon's first drug candidate, HPN424, is currently in Phase 1 clinical trial as a treatment for prostate cancer.
HARPOON THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.harpoontx.com
Total Employee:
51+
Status:
Active
Contact:
650-443-7400
Email Addresses:
[email protected]
Total Funding:
130 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Apache Microsoft Exchange Online
Similar Organizations
Aletheia Therapeutics
Aletheia Therapeutics is a clinical-stage oncology therapeutics company that develops a paradigm shift in the treatment of cancer.
amcure
amcure is a clinical-stage company develops peptide-based compounds for the treatment of highly metastatic forms of squamous cancer.
Atara Biotherapeutics
Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.
Atsena Therapeutics
Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
GamaMabs Pharma
GamaMabs Pharma is a clinical-stage immuno-oncology company that developes optimized therapeutic antibodies for the treatment of cancer.
Inspyr Therapeutics
Inspyr Therapeutics is a clinical stage company focused on novel targeted precision therapeutics for the treatment of cancer.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Guided Therapeutics
Guided Therapeutics is a medical technology company developing biophotonics solutions for the non-invasive detection of cancer.
Juno Therapeutics
Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Kurome Therapeutics
Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy.
Marker Therapeutics
Marker Therapeutics is a clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Sierra Oncology
Sierra Oncology is a clinical-stage drug development company that advances targeted therapeutics for the treatment of cancer patients.
Valanbio Therapeutics
Valanbio Therapeutics is an early-stage anti-infectives company that develops novel antibiotics for Gram-negative organisms.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
MPM Capital
MPM Capital investment in Series C - Harpoon Therapeutics
UBS Asset Management
UBS Asset Management investment in Series C - Harpoon Therapeutics
OrbiMed
OrbiMed investment in Series C - Harpoon Therapeutics
oncology impact fund
oncology impact fund investment in Series C - Harpoon Therapeutics
NS Investment
NS Investment investment in Series C - Harpoon Therapeutics
New Leaf Venture Partners
New Leaf Venture Partners investment in Series C - Harpoon Therapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series C - Harpoon Therapeutics
Ridgeback Capital
Ridgeback Capital investment in Series C - Harpoon Therapeutics
Arix Bioscience
Arix Bioscience investment in Series C - Harpoon Therapeutics
Taiho Ventures
Taiho Ventures investment in Series C - Harpoon Therapeutics
Official Site Inspections
http://www.harpoontx.com Semrush global rank: 3.44 M Semrush visits lastest month: 4.46 K
- Host name: ad8242ffdb37e18fd.awsglobalaccelerator.com
- IP address: 75.2.16.51
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
